Elevance Health Inc.
(ELV)
undefined
undefined%
At close: undefined
379.65
0.08%
After-hours Jan 06, 2025, 07:00 PM EST
Company Description
Elevance Health Inc. operates as a health benefits company.
It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives.
It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions.
The company was formerly known as Anthem, Inc. and changed its name to Elevance Health Inc. in June 2022.
Elevance Health Inc. was founded in 1944 and is headquartered in Indianapolis, Indiana.
Elevance Health Inc.
| Country | United States |
| IPO Date | Oct 30, 2001 |
| Industry | Medical - Healthcare Plans |
| Sector | Healthcare |
| Employees | 104,900 |
| CEO | Gail Koziara Boudreaux |
Contact Details
Address: 220 Virginia Avenue Indianapolis, Indiana United States | |
| Website | https://www.elevancehealth.com |
Stock Details
| Ticker Symbol | ELV |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001156039 |
| CUSIP Number | 036752103 |
| ISIN Number | US0367521038 |
| Employer ID | 35-2145715 |
| SIC Code | 6324 |
Key Executives
| Name | Position |
|---|---|
| Gail Koziara Boudreaux | President, Chief Executive Officer & Director |
| Kyle Weber | Chief Strategy Officer & Interim Chief Marketing Officer |
| Mark Bradley Kaye | Executive Vice President & Chief Financial Officer |
| Blair Williams Todt | Executive Vice President and Chief Legal & Administrative Officer |
| Felicia Farr Norwood | Executive Vice President & President of Government Health Benefits |
| Julie Goon | Senior Vice President of Public Affairs |
| Peter David Haytaian Esq. | Executive Vice President and President of Carelon & CarelonRx |
| Ronald William Penczek | Senior Vice President, Controller & Chief Accounting Officer |
| Scott Wayne Anglin | SVice President, Treasurer & Chief Investment Officer |
| Stephen Vartan Tanal C.F.A. | Vice President of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 05, 2024 | 4 | Filing |
| Nov 05, 2024 | 4 | Filing |
| Oct 31, 2024 | 8-K | Current Report |
| Oct 23, 2024 | 424B3 | Filing |
| Oct 22, 2024 | FWP | Filing |
| Oct 22, 2024 | 424B3 | Filing |
| Oct 18, 2024 | 4 | Filing |
| Oct 17, 2024 | 10-Q | Quarterly Report |
| Oct 17, 2024 | 8-K | Current Report |